Mitchel Sayare, Director at Altimmune, Inc. (ALT), bought 5,100 shares at $1.95 ($10K) on 2017-12-29, disclosed to the SEC on 2018-01-03.
Open-market purchase of $10k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| IMGN | SELL | 2011-07-18 | $150K | — | Filing → |
| IMGN | SELL | 2011-06-27 | $117K | — | Filing → |
| IMGN | SELL | 2011-06-13 | $117K | — | Filing → |